Close Menu
Gun and TacticalGun and Tactical
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Facebook X (Twitter) Instagram
Gun and TacticalGun and Tactical
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Subscribe
Gun and TacticalGun and Tactical
  • News
  • Guns and Gear
  • Prepping & Survival
  • Tactical
  • Videos
Home » Russia’s Cancer Vaccine Administered To Melanoma Patient
Prepping & Survival

Russia’s Cancer Vaccine Administered To Melanoma Patient

David LuttrellBy David LuttrellApril 2, 20262 Mins Read
Facebook Twitter Pinterest WhatsApp Telegram Email LinkedIn Tumblr
Russia’s Cancer Vaccine Administered To Melanoma Patient

The Russian Ministry of Health announced yesterday that doctors at the National Medical Research Center for Radiology administered the country’s first domestically developed personalized mRNA-based cancer vaccine. The patient who received the vaccine is a 60-year-old melanoma patient.

Neooncovac, is the first domestically developed personalized mRNA-based cancer vaccine.

First Test Batches of Russia’s AI-assisted Cancer Vaccine Have Been Created

According to Doolly, his therapeutic vaccine, created using the patient’s unique tumor-specific mutations and molecular-genetic characteristics, works as an individualized anti-tumor treatment by encoding neoantigens into mRNA delivered via lipid nanoparticles. It trains the immune system to mount a targeted T-cell response against cancer cells while aiming to minimize harm to healthy tissue.

Neooncovac is authorized for adult patients with inoperable or metastatic cutaneous melanoma, often alongside immunotherapy.

Other countries have been looking into using artificial intelligence in order to create and test cancer vaccines.

UK Will Be The First to Trial BioNTech’s mRNA Cancer “Vaccines.”

mRNA “Vaccines” Facing Backlash?

Personalized cancer vaccines differ fundamentally from conventional preventive vaccines. They serve as therapeutic vaccines designed to treat existing disease by harnessing the patient’s immune system. The approach relies on identifying neoantigens—unique proteins generated by tumor-specific mutations present only in cancer cells. –Doolly

After the injection, the mRNA in the vaccine instructs the patient’s cells to produce neoantigens, then presents them to the immune system. This stimulates a targeted T-cell response and broader immune response, training the body to recognize and eliminate cancer cells bearing the same mutations. Because the vaccine focuses on patient-specific alterations, it aims to minimize effects on healthy tissue while potentially creating long-term immune memory against recurrence.

Russian researchers built on expertise gained from prior mRNA work, including platforms developed during the COVID-19 response.

Who Is At Fault When Americans Distrust COVID “Vaccines?” Russia, Of Course!

Many still don’t trust mRNA vaccines after the rushed COVID-19 injections were all but forced on the public. Perhaps if the science goes in a more favorable direction, people will start to actually trust thsoe who are right now, only making money off of ailments and sicknesses.

Read the full article here
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Oil Spikes As Trump Vows To Hit Iran “Extremely Hard Over Next 2-3 Weeks”

Iran May Hit the U.S.—Here’s How to Be Ready

What the US Embassy Attack in Baghdad Means for Preppers

How AI Is Rewiring You Without You Knowing It

Red Dawn (1984): The Classic Prepper Movie?

Grid-Down Hygiene: How to Stay Clean in a Crisis

Editor's Picks

Iran’s tallest bridge collapses after reported US airstrikes, Iran threatens American allies in retaliation

April 2, 2026

USS Gerald R. Ford returns to sea after brief stop in Croatia

April 2, 2026

NYC Gun License Applicants Sue NYPD Over Years-Long Delays That Blocked Their Second Amendment Rights

April 2, 2026

Texas Tech booster Cody Campbell feuds with Big 12’s Brett Yormark over Friday night game move

April 2, 2026

Trump Replaces Pam Bondi as AG, Names Todd Blanche

April 2, 2026

Type above and press Enter to search. Press Esc to cancel.